| scholarly article | Q13442814 |
| P356 | DOI | 10.1098/RSIF.2013.0414 |
| P8608 | Fatcat ID | release_7rsvv5ohnvbbjdf2lbos2vx6je |
| P932 | PMC publication ID | 3730691 |
| P698 | PubMed publication ID | 23825116 |
| P5875 | ResearchGate publication ID | 245029232 |
| P50 | author | Nicholas G. Reich | Q52376096 |
| Derek Cummings | Q60057514 | ||
| Siripen Kalayanarooj | Q60059354 | ||
| Pejman Rohani | Q89042550 | ||
| Justin Lessler | Q37366488 | ||
| Sourya Shrestha | Q41050098 | ||
| Aaron A. King | Q41050114 | ||
| P2093 | author name string | Donald S Burke | |
| Robert V Gibbons | |||
| In-Kyu Yoon | |||
| P2860 | cites work | Dengue virus pathogenesis: an integrated view | Q24645380 |
| Neutralizing antibodies after infection with dengue 1 virus | Q24652746 | ||
| A new look at the statistical model identification | Q26778401 | ||
| Dynamic effects of antibody-dependent enhancement on the fitness of viruses | Q27472667 | ||
| The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens | Q27473404 | ||
| Ecological and immunological determinants of dengue epidemics | Q27473480 | ||
| Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok | Q27477511 | ||
| Concurrent infections by all four dengue virus serotypes during an outbreak of dengue in 2006 in Delhi, India | Q27485430 | ||
| Asymmetric competitive suppression between strains of dengue virus | Q27485457 | ||
| Cross-reacting antibodies enhance dengue virus infection in humans | Q28281588 | ||
| A prospective study of dengue infections in Bangkok | Q28296365 | ||
| Dengue: a continuing global threat | Q28298464 | ||
| Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial | Q29616259 | ||
| Neutralization and antibody-dependent enhancement of dengue viruses | Q29618172 | ||
| Unifying the epidemiological and evolutionary dynamics of pathogens | Q29619092 | ||
| Research on dengue during World War II | Q29619423 | ||
| Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever | Q29619530 | ||
| Ecological and immunological determinants of influenza evolution. | Q30332657 | ||
| Common occurrence of concurrent infections by multiple dengue virus serotypes. | Q30823394 | ||
| Constancy of distribution of serogroups of invasive pneumococcal isolates among children: experience during 4 decades. | Q30985089 | ||
| Statistical inference for multi-pathogen systems | Q34005264 | ||
| Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity | Q35895444 | ||
| Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes | Q35927343 | ||
| Revealing the microscale spatial signature of dengue transmission and immunity in an urban population | Q36066463 | ||
| Antigenic groupings of 90 rhinovirus serotypes | Q36331365 | ||
| Conquering the meningococcus | Q36711456 | ||
| Decreases in dengue transmission may act to increase the incidence of dengue hemorrhagic fever | Q36883189 | ||
| Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection | Q38087545 | ||
| Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks | Q39038287 | ||
| Dengue 1 virus and dengue hemorrhagic fever, French Polynesia, 2001. | Q40380039 | ||
| Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences. | Q40435198 | ||
| Inferring the timescale of dengue virus evolution under realistic models of DNA substitution. | Q40448490 | ||
| Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes. | Q40468558 | ||
| Chaotic desynchronization of multistrain diseases | Q40485854 | ||
| Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys | Q40514694 | ||
| Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. | Q40563390 | ||
| The dengue group of viruses and its family relationships. | Q41064239 | ||
| Dynamical behavior of epidemiological models with nonlinear incidence rates | Q44094769 | ||
| Naturally acquired immunity to influenza type A: a further prospective study | Q45273984 | ||
| Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections | Q45852624 | ||
| Interpreting time-series analyses for continuous-time biological models--measles as a case study | Q47867158 | ||
| Antigenic Diversity in the Human Malaria Parasite Plasmodium falciparum | Q47973891 | ||
| P433 | issue | 86 | |
| P921 | main subject | Dengue virus | Q476209 |
| epidemiology | Q133805 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 20130414 | |
| P577 | publication date | 2013-07-03 | |
| P1433 | published in | Journal of the Royal Society Interface | Q2492390 |
| P1476 | title | Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity | |
| P478 | volume | 10 |
| Q89552802 | A Review on Dengue Vaccine Development |
| Q34044677 | A review of West Nile and Usutu virus co-circulation in Europe: how much do transmission cycles overlap? |
| Q40134826 | A role for vector control in dengue vaccine programs |
| Q63246309 | An agent-based model of dengue virus transmission shows how uncertainty about breakthrough infections influences vaccination impact projections |
| Q38156746 | An economic evaluation of vector control in the age of a dengue vaccine |
| Q78177450 | An open challenge to advance probabilistic forecasting for dengue epidemics. |
| Q33650118 | Anti-Idiotypic Antibodies Specific to prM Monoantibody Prevent Antibody Dependent Enhancement of Dengue Virus Infection |
| Q47592202 | Antibody-dependent enhancement of severe dengue disease in humans |
| Q92936610 | Assessing dengue control in Tokyo, 2014 |
| Q38837531 | Assessing dengue vaccination impact: Model challenges and future directions |
| Q28656188 | Assessing the relationship between vector indices and dengue transmission: a systematic review of the evidence |
| Q36131935 | Association of FcγRIIa Polymorphism with Clinical Outcome of Dengue Infection: First Insight from Pakistan |
| Q57091779 | Autochthonous spread of DENV-3 genotype III in Malaysia mitigated by pre-existing homotypic and heterotypic immunity |
| Q26746185 | Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment |
| Q61809674 | Biased efficacy estimates in phase-III dengue vaccine trials due to heterogeneous exposure and differential detectability of primary infections across trial arms |
| Q36187799 | Big city, small world: density, contact rates, and transmission of dengue across Pakistan |
| Q35760439 | CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice |
| Q54238236 | Challenges in dengue research: A computational perspective |
| Q52662743 | Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines |
| Q91638468 | Coinfections by noninteracting pathogens are not independent and require new tests of interaction |
| Q91807708 | Considering Genomic and Immunological Correlates of Protection for a Dengue Intervention |
| Q55119556 | Contributions from the silent majority dominate dengue virus transmission. |
| Q56341981 | Cross-reactive Dengue virus-specific CD8 T cells protect against Zika virus during pregnancy |
| Q36745257 | Dengue Virus (DENV) Neutralizing Antibody Kinetics in Children After Symptomatic Primary and Postprimary DENV Infection |
| Q83229772 | Dengue genetic divergence generates within-serotype antigenic variation, but serotypes dominate evolutionary dynamics |
| Q35458940 | Dengue on islands: a Bayesian approach to understanding the global ecology of dengue viruses |
| Q34042859 | Dengue serotype cross-reactive, anti-e protein antibodies confound specific immune memory for 1 year after infection |
| Q37270826 | Dengue serotype immune-interactions and their consequences for vaccine impact predictions |
| Q42985743 | Dengue vaccine: hypotheses to understand CYD-TDV-induced protection |
| Q34351011 | Dengue virus neutralizing antibody levels associated with protection from infection in thai cluster studies |
| Q45324929 | Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge |
| Q36926525 | Dengue viruses cluster antigenically but not as discrete serotypes |
| Q28729764 | Dengue: knowledge gaps, unmet needs, and research priorities |
| Q27468688 | DengueME: A Tool for the Modeling and Simulation of Dengue Spatiotemporal Dynamics |
| Q36340065 | Determination of clusters and factors associated with dengue dispersion during the first epidemic related to Dengue virus serotype 4 in Vitória, Brazil |
| Q64125827 | Development of Dengue-type NS1 ELISA for Rapid Detection and Differentiation of Dengue Serotypes during Early Infection |
| Q34470326 | Eight challenges in phylodynamic inference. |
| Q58744923 | Epidemic dynamics, interactions and predictability of enteroviruses associated with hand, foot and mouth disease in Japan |
| Q38935048 | Epidemiological and molecular features of dengue virus type-1 in New Caledonia, South Pacific, 2001-2013. |
| Q21131163 | Epidemiological risk factors associated with high global frequency of inapparent dengue virus infections |
| Q30202800 | Epidemiological update on the dengue situation in the Western Pacific Region, 2012. |
| Q59245629 | Epidemiology of dengue and other arboviruses in a cohort of school children and their families in Yucatan, Mexico: Baseline and first year follow-up |
| Q31113799 | Estimating Dengue Transmission Intensity from Case-Notification Data from Multiple Countries |
| Q35448628 | Estimating dengue transmission intensity from sero-prevalence surveys in multiple countries. |
| Q35117172 | Estimating drivers of autochthonous transmission of chikungunya virus in its invasion of the americas |
| Q31032490 | Estimating the Attack Ratio of Dengue Epidemics under Time-varying Force of Infection using Aggregated Notification Data |
| Q40081496 | Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies |
| Q37281981 | Evaluating the performance of infectious disease forecasts: A comparison of climate-driven and seasonal dengue forecasts for Mexico |
| Q30248269 | Forecasting Epidemiological and Evolutionary Dynamics of Infectious Diseases |
| Q56353070 | Forecasting the effectiveness of indoor residual spraying for reducing dengue burden |
| Q35925175 | Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination. |
| Q27980556 | Heterologous Protection against Asian Zika Virus Challenge in Rhesus Macaques |
| Q92188304 | Host contact dynamics shapes richness and dominance of pathogen strains |
| Q33853984 | How season and serotype determine dengue transmissibility |
| Q35865977 | Human Social Behavior and Demography Drive Patterns of Fine-Scale Dengue Transmission in Endemic Areas of Colombia |
| Q33924674 | Immune correlates for dengue vaccine development |
| Q38652971 | Immune correlates of protection for dengue: State of the art and research agenda |
| Q30151102 | Impact of human mobility on the emergence of dengue epidemics in Pakistan |
| Q92024402 | Impacts of Zika emergence in Latin America on endemic dengue transmission |
| Q28550030 | Incomplete Protection against Dengue Virus Type 2 Re-infection in Peru |
| Q56428059 | Inferences about spatiotemporal variation in dengue virus transmission are sensitive to assumptions about human mobility: a case study using geolocated tweets from Lahore, Pakistan |
| Q90468197 | Influence of herd immunity in the cyclical nature of arboviruses |
| Q90698532 | Interplay between competitive and cooperative interactions in a three-player pathogen system |
| Q91605068 | Intra-host growth kinetics of dengue virus in the mosquito Aedes aegypti |
| Q26279016 | Invasion Dynamics of Teratogenic Infections in Light of Rubella Control: Implications for Zika Virus |
| Q38618056 | Key concepts, strategies, and challenges in dengue vaccine development: an opportunity for sub-unit candidates? |
| Q91650081 | Long-Term Protection Elicited by a DNA Vaccine Candidate Expressing the prM-E Antigen of Dengue Virus Serotype 3 in Mice |
| Q35746499 | Meteorologically Driven Simulations of Dengue Epidemics in San Juan, PR |
| Q35009344 | Minimal within-host dengue models highlight the specific roles of the immune response in primary and secondary dengue infections |
| Q24277713 | Modeling infectious disease dynamics in the complex landscape of global health |
| Q92290575 | Multi-Lineage Evolution in Viral Populations Driven by Host Immune Systems |
| Q36498207 | Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort |
| Q34078369 | Pathogen evolution and the immunological niche |
| Q35152094 | Potent dengue virus neutralization by a therapeutic antibody with low monovalent affinity requires bivalent engagement |
| Q63246842 | Practical unidentifiability of a simple vector-borne disease model: Implications for parameter estimation and intervention assessment |
| Q31065710 | Prediction of Dengue Outbreaks Based on Disease Surveillance and Meteorological Data |
| Q64064326 | Prediction of dengue outbreaks based on disease surveillance, meteorological and socio-economic data |
| Q35221318 | Preexisting neutralizing antibody responses distinguish clinically inapparent and apparent dengue virus infections in a Sri Lankan pediatric cohort |
| Q36030395 | Projected Impact of Dengue Vaccination in Yucatán, Mexico |
| Q49790241 | Prospective forecasts of annual dengue hemorrhagic fever incidence in Thailand, 2010-2014. |
| Q56788369 | Quantifying the added value of climate information in a spatio-temporal dengue model |
| Q37635100 | Recasting the theory of mosquito-borne pathogen transmission dynamics and control |
| Q59055979 | Reconstruction of antibody dynamics and infection histories to evaluate dengue risk |
| Q34640272 | Review article: Research on dengue during World War II revisited |
| Q33997466 | Risk of dengue for tourists and teams during the World Cup 2014 in Brazil |
| Q35211928 | Sequential dengue virus infections detected in active and passive surveillance programs in Thailand, 1994-2010. |
| Q40204952 | Sequential episodes of dengue--Puerto Rico, 2005-2010. |
| Q35370876 | Severity of bovine tuberculosis is associated with co-infection with common pathogens in wild boar |
| Q38773323 | Status of vaccine research and development of vaccines for dengue |
| Q93176733 | Synchronous shedding of multiple bat paramyxoviruses coincides with peak periods of Hendra virus spillover |
| Q28114613 | Synchrony of Dengue Incidence in Ho Chi Minh City and Bangkok |
| Q38655102 | Temperature modulates dengue virus epidemic growth rates through its effects on reproduction numbers and generation intervals |
| Q39119333 | The Influence of Spatial Configuration of Residential Area and Vector Populations on Dengue Incidence Patterns in an Individual-Level Transmission Model |
| Q36206692 | The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study |
| Q39141924 | The Potential Impact of Vaccination on the Dynamics of Dengue Infections |
| Q36012107 | The Role of Serotype Interactions and Seasonality in Dengue Model Selection and Control: Insights from a Pattern Matching Approach |
| Q40197239 | The introduction of dengue vaccine may temporarily cause large spikes in prevalence |
| Q51782689 | The use of longitudinal cohorts for studies of dengue viral pathogenesis and protection |
| Q55333503 | Transmission-clearance trade-offs indicate that dengue virulence evolution depends on epidemiological context. |
| Q90747602 | Trends in the Mechanistic and Dynamic Modeling of Infectious Diseases |
| Q54226258 | Understanding dengue virus evolution to support epidemic surveillance and counter-measure development. |
| Q30829948 | Whither vaccines? |
| Q41993412 | tsiR: An R package for time-series Susceptible-Infected-Recovered models of epidemics |
Search more.